Director, National Accounts

Tonix is a fully integrated biotechnology company, publicly traded on NASDAQ (ticker: TNXP), with marketed products and a pipeline of development candidates. The Company is focused on commercializing, developing, discovering, and licensing therapeutics to treat and prevent human disease. In August 2025, Tonix received FDA approval for Tonmya™ (cyclobenzaprine HCl sublingual tablets), a first‑in‑class, once‑daily, non‑opioid treatment for fibromyalgia. Tonmya is the first new fibromyalgia therapy approved in over 15 years, following successful Phase 3 trials demonstrating significant symptom improvement.

Commercial launch is expected in the fourth quarter of 2025. Tonix also markets Zembrace® Sym Touch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg, both indicated for the treatment of acute migraine with or without aura in adults.

Tonix’s development portfolio includes product candidates in central nervous system (CNS), immunology, immuno‑oncology, infectious disease and rare disease. The CNS pipeline features both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. The immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. The infectious disease pipeline includes a vaccine in development to prevent smallpox and monkeypox, which also serves as a live virus vaccine platform for other infectious diseases.

Finally, therare disease portfolio includes a product in development for Prader‑Willi syndrome, which has both orphan drug designation and rare pediatric disease designation grants from the FDA.

Tonix owns and operates a state‑of‑the‑art infectious disease research facility in Frederick, Md.

Please visit  for specifics on the pipeline.

* All of Tonix’s product candidates are investigational new drugs or biologics and have not been approved for any indication.

The National Account Director (NAD), Payers at Tonix Pharmaceuticals will be responsible for leadership and management of select national and sub‑national payer and other assigned accounts. These accounts include health insurance companies, PBMs, Medicare, state Medicaid, large IDNs, among others. The NAD will be responsible for building and maintaining strong relationships with medical and pharmacy departments. This role involves executing strategies and tactics within each account, while also providing support to the sales team when necessary.

A strong understanding of managed markets, reimbursement, and payer account management is essential.

The individual will effectively communicate the value of Tonix Pharmaceuticals’ product portfolio to the market, collaborate with field sales to address market access inquiries, and help develop strategies to overcome coverage barriers. Additionally, the role requires working cross‑functionally with key internal teams, including Medical, Marketing, Contracting, Government Reporting, Legal, Compliance, Sales, Reimbursement, and Patient Services, to ensure cohesive execution and advocacy.

This position will report directly to the Vice President, Market Access and will be based remotely.

• Establish, broaden, and deepen relationships with target entities (e.g., health insurers, PBMs, other payers, etc.) and key decision makers and influencers (pharmacy and medical directors, etc.) that affect coverage and reimbursement decisions.
• Positively influence decision makers, policies, guidelines and contracts to facilitate timely and appropriate coverage, access and reimbursement for our drug candidates and approved products.
• Develop account specific plans and assist in the resolution of access/reimbursement issues.
• Work closely with the MSL team to support the communication and understanding of our drug candidates and approved products with payers.
• Work closely with the Patient Services team to support the patient journey and resolve coverage issues.
• Assist Regional Sales teams with pull‑ or sell‑through strategies based on payer coverage.
• Represent Tonix at industry events, including Asembia, AMCP, and other relevant conferences.
• Uphold the highest standards of professionalism,…